Les Sulewski
Stock Analyst at Truist Securities
(1.16)
# 3,670
Out of 5,146 analysts
17
Total ratings
53.33%
Success rate
-11.55%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Les Sulewski
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TEVA Teva Pharmaceutical Industries | Maintains: Buy | $38 → $42 | $33.77 | +24.37% | 3 | Feb 18, 2026 | |
| BHC Bausch Health Companies | Maintains: Hold | $7 → $8 | $6.04 | +32.45% | 1 | Jan 7, 2026 | |
| PCRX Pacira BioSciences | Maintains: Buy | $30 → $28 | $22.59 | +23.95% | 7 | Nov 7, 2025 | |
| COLL Collegium Pharmaceutical | Maintains: Buy | $45 → $48 | $44.22 | +8.55% | 3 | Nov 7, 2025 | |
| AMRX Amneal Pharmaceuticals | Maintains: Buy | $10 → $12 | $14.49 | -17.18% | 3 | Oct 2, 2024 |
Teva Pharmaceutical Industries
Feb 18, 2026
Maintains: Buy
Price Target: $38 → $42
Current: $33.77
Upside: +24.37%
Bausch Health Companies
Jan 7, 2026
Maintains: Hold
Price Target: $7 → $8
Current: $6.04
Upside: +32.45%
Pacira BioSciences
Nov 7, 2025
Maintains: Buy
Price Target: $30 → $28
Current: $22.59
Upside: +23.95%
Collegium Pharmaceutical
Nov 7, 2025
Maintains: Buy
Price Target: $45 → $48
Current: $44.22
Upside: +8.55%
Amneal Pharmaceuticals
Oct 2, 2024
Maintains: Buy
Price Target: $10 → $12
Current: $14.49
Upside: -17.18%